About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Multiple Myeloma - Promises and Perils of Immunotherapy
By
Parameswaran Hari
6 Videos
218 views
August 6, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
14:41
Sanofi
Efficacy and Safety of a Treatment Option for Adults with Multiple M…
Feat.
J. Mikhael
Featured Video
15:18
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations for Ibrutinib-Intolerant Patients - A Patie…
Feat.
M. Shadman
Related Content
AUTOPLAY
ON
07:11
GRACE
CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…
Feat.
A. Goodman,
A. Jeong,
S. Rajeeve
16:42
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…
Feat.
H. Hashmi
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
14:09
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…
Feat.
H. Hashmi
12:35
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Treatment Options for Patients With Myelo…
Feat.
C. Cerchione
04:08
GRACE
CAR T-Cell Therapy Side Effects for Blood Cancers
Feat.
A. Goodman
49:01
Scripps MD Anderson Cancer Center
Current Summary of the Multiple Myeloma Treatment Landscape
Feat.
R. Lu
08:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Speci…
Feat.
R. Bansal
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
20:18
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Will Immune Therapy Replace Transplant in Hematologic Malignancies?
Feat.
R. Gale
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
The Improbable History of CAR T-Cells
Feat.
C. June
03:17
Insights from 2023 IMS Annual Meeting
IMS 2023 Insights: "Highlights From the International Myeloma S…
Feat.
J. Richter
21:17
5th SOHO Italy Annual Conference
Health-Related Quality of Life in R/R MM
Feat.
M. Delforge
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
44:49
Dana-Farber Cancer Institute
Recent Updates in Multiple Myeloma
Feat.
K. Anderson
32:03
Indy Hematology Review
Emerging and Current Treatment of MM: What Should We Know and What S…
Feat.
K. Anderson
17:13
Insights from 2023 ASH Annual Meeting
Updates From ASH: The Evolving Role and Sequencing of Bispecifics an…
Feat.
A. Jakubowiak
18:27
Indy Hematology Review
DEBATE: Why Not to Transplant When MRD Has Been Achieved After Initi…
Feat.
J. Mikhael